Atara Biotherapeutics, Inc.
ATRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001604464
In the last 90 days, Atara Biotherapeutics, Inc. insiders filed 1 open-market purchase and 1 sale; 36 institutions reported holding it in 13F filings for Q2 2026, worth $51.3M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Atara Biotherapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −5 vs. Q1 2025
- Shares held
- 1.80M
- −283.4K (−13.6%) vs. Q1 2025
- Total value
- $13.9M
- +$1.53M (+12.3%) vs. Q1 2025
- New holders
- 4
- 5 more added
- Sold out
- 9
- 6 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $51.3M |
| Q1 2026 | 33 | $12.1M |
| Q4 2025 | 41 | $37.1M |
| Q3 2025 | 37 | $27.0M |
| Q2 2025 | 32 | $13.9M |
| Q1 2025 | 37 | $12.4M |
| Q4 2024 | 43 | $31.5M |
| Q3 2024 | 35 | $19.6M |
| Q2 2024 | 48 | $24.1M |
| Q1 2024 | 82 | $57.8M |
| Q4 2023 | 91 | $33.2M |
| Q3 2023 | 109 | $130.5M |
| Q2 2023 | 118 | $145.8M |
| Q1 2023 | 125 | $297.8M |
| Q4 2022 | 139 | $319.3M |
| Q3 2022 | 155 | $376.2M |
| Q2 2022 | 134 | $777.4M |
| Q1 2022 | 145 | $909.5M |
| Q4 2021 | 139 | $1.50B |
| Q3 2021 | 140 | $1.61B |
| Q2 2021 | 145 | $1.34B |
| Q1 2021 | 151 | $1.24B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Atara Biotherapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 10 | $77 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 50 | $386 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 148 | $1.14K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 175 | $1.35K | 0.00% | 00.0% | Unchanged |
| Banque Transatlantique SA | 176 | $1.37K | 0.00% | 00.0% | Unchanged |
| Raiffeisen Bank International AG | 200 | $1.54K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 216 | $1.67K | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 703 | $5.60K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 951 | $7.34K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 1,404 | $10.8K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,450 | $12.0K | 0.00% | +600+70.6% | Added |
| Raymond James Financial Inc | 4,021 | $31.0K | 0.00% | +4,021 | New |
| Bank of America Corp | 7,688 | $59.4K | 0.00% | −179,609−95.9% | Reduced |
| UBS Group AG | 8,385 | $64.7K | 0.00% | −15,949−65.5% | Reduced |
| Northern Trust Corp | 11,170 | $86.2K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 14,000 | $108.1K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 14,926 | $115.2K | 0.00% | +3,098+26.2% | Added |
| Renaissance Technologies LLC | 16,936 | $130.7K | 0.00% | −500−2.9% | Reduced |
| FMR LLC | 17,156 | $132.4K | 0.00% | −10.0% | Reduced |
| Gsa Capital Partners LLP | 19,591 | $151.0K | 0.01% | +206+1.1% | Added |
| Mackenzie Financial Corp | 22,514 | $173.8K | 0.00% | +22,514 | New |
| Citadel Advisors LLC | 23,003 | $177.6K | 0.00% | +23,003 | New |
| State Street Corp | 25,253 | $195.0K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 42,355 | $327.0K | 0.00% | +42,355 | New |
| Geode Capital Management, LLC | 60,136 | $464.3K | 0.00% | +1,457+2.5% | Added |
| Acadian Asset Management LLC | 65,155 | $502.0K | 0.00% | −49,956−43.4% | Reduced |
| BlackRock, Inc. | 70,848 | $546.9K | 0.00% | +10,050+16.5% | Added |
| Staley Capital Advisers Inc | 75,000 | $579.0K | 0.02% | −5,000−6.3% | Reduced |
| Vestal Point Capital, LP | 94,085 | $726.3K | 0.04% | 00.0% | Unchanged |
| Vanguard Group Inc | 190,761 | $1.47M | 0.00% | 00.0% | Unchanged |
| Redmile Group, LLC | 441,701 | $3.41M | 0.36% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 573,183 | $4.42M | 0.26% | 00.0% | Unchanged |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −75,196−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −41,014−100.0% | Sold out |
| Birchview Capital, LP | 0 | $0 | 0.00% | −22,000−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −421−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −368−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −368−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −185−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −180−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |